Clinical Trial Update: Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and blood collection study of a meningococcal B vaccine (RLP2086) in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• RLP2086 meningococcal B vaccine (RLP2086)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Meningitis, Meningococcal | Phase 1, Phase 2 | Status: COMPLETED